Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (RXRX)
CUSIP: 75629V104
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 336,160,522
- Total 13F value
- $1,032,087,537
- Share change
- +10,793,498
- Put/Call ratio
- 64%
- SEC-reported price per share
- $3.07
- Number of holders
- 331
- Value change
- +$24,688,561
- Number of buys
- 182
- Number of sells
- 127
- Shares outstanding
- 525,850,455
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
331
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARK Investment Management...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2025
13D/G
13F
Lead comparable stake: 7.2%
13D/G row: ARK Investment Management LLC
Showing 1-6 of 15 holder rows.
Quick read
ARK Investment Management LLC leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARK Investment Management LLC's linked filing trail.
Comparable ownership
Top 5
ARK Investment Management LLC
7.2%
STATE STREET CORP
5.5%
BAILLIE GIFFORD & CO
4.6%
RA CAPITAL MANAGEMENT, L.P.
2%
VANGUARD GROUP INC
9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARK Investment Management LLC |
13D/G
13F
Company
|
7.2%
|
$152,625,941
37,316,856 shares
|
+$20,329,177 | 31 Dec 2025 |
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
5.5%
from 13D/G
|
$103,615,602
25,333,888 shares
|
— | 31 Dec 2025 |
| BAILLIE GIFFORD & CO |
13D/G
13F
Company
|
4.6%
|
$97,239,635
23,774,972 shares
|
$0 | 31 Dec 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
2%
|
$44,187,549
7,725,096 shares
|
$0 | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9%
|
$192,997,934
47,187,759 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
7.4%
|
$158,965,127
38,866,779 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
331
Shares
336,160,522
Rows available
331
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
331
Q1 2026 holders
331
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|